Quarterly Transactions Made in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR). The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 2,480 | 118,396 | 120,876 | 0 | 50,436 | 50,436 | 70,440 | |
| Q3 2021 | 13,060 | 4,700 | 17,760 | 2,096 | 58 | 2,154 | 15,606 | |
| Q4 2021 | 311 | 6,675 | 6,986 | 419 | 0 | 419 | 6,567 | |
| Q1 2022 | 1,203 | 1,201 | 2,404 | 1,271 | 177 | 1,448 | 956 | |
| Q2 2022 | 16,458 | 1,380 | 17,838 | 12,588 | 1,001 | 13,589 | 4,249 | |
| Q3 2022 | 1,931 | 10,642 | 12,573 | 14,162 | 2,327 | 16,489 | -3,916 | |
| Q4 2022 | 2,819 | 10,705 | 13,524 | 2,838 | 0 | 2,838 | 10,686 | |
| Q1 2023 | 4,204 | 30,869 | 35,073 | 2,118 | 0 | 2,118 | 32,955 | |
| Q2 2023 | 3,022 | 32,911 | 35,933 | 800 | 0 | 800 | 35,133 | |
| Q3 2023 | 0 | 138,252 | 138,252 | 15,479 | 0 | 15,479 | 122,773 | |
| Q4 2023 | 12,363 | 118,363 | 130,726 | 45,958 | 0 | 45,958 | 84,768 | |
| Q1 2024 | 168,778 | 42,193 | 210,971 | 12,674 | 0 | 12,674 | 198,297 | |
| Q2 2024 | 21,844 | 47,058 | 68,902 | 4,987 | 0 | 4,987 | 63,915 | |